Instant Savings Offer*SAVE NOW

See clinical trial results

16-year-old female patient
treated with onexton

Baseline and After Results

After 12 Weeks

Baseline and After Results

Baseline

15-year-old male patient
treated with onexton

Baseline and After Results

After 12 Weeks

Baseline and After Results

Baseline

31-year-old female patient
treated with onexton

Baseline and After Results

After 12 Weeks

Baseline and After Results

Baseline

14-year-old male patient
treated with onexton

Baseline and After Results

After 12 Weeks

Baseline and After Results

Baseline

Photos have not been retouched. Individual results may vary.

Patients in the ONEXTON clinical trial were 12 years of age and older with moderate-to-severe acne. This means they had anywhere between 20-40 pimples or 20-100 whiteheads and/or blackheads before they started the trial. During the trial, patients applied either ONEXTON Gel or a gel with no other medication once a day for 12 weeks.

Results in a clinical study

  • Patients taking ONEXTON (N=253) experienced an average 60% reduction in their inflammatory acne (pimples) at 12 weeks, compared to a 31% reduction in the control group (N=245)
  • Patients taking ONEXTON achieved an average 52% reduction in their comedonal acne (whiteheads and blackheads) at 12 weeks, compared to 28% in the control group
  • The most common side effect with ONEXTON gel was skin irritation. See Important Safety Information below for more serious, less frequent, side effects.

What can I expect?

Many patients see significant results at 12 weeks with ONEXTON. To get the best results, apply regularly as directed by your doctor.